Klinefelter syndrome is an consequence of what type of mutation?
a. deletion
b. insertion
c. frame shift
d. nondisjunction

Which taxon group is more specific, in regards to organisms that are in that group? mammalia animalia

Interpret the model. a three-part model with black right-arrows between the parts. left part: a large green apple-shaped component with a w-shaped indentation centered on top. a small blue apple-slice shape sits above the left indentation and an arrow points from the shape to the indentation. a small purple apple-slice shape and arrow sit above the right indentation and an arrow points from the shape to the indentation. middle part: a large green apple-shaped component with a square indentation centered on top. sitting in the left side of the indentation is a blue apple-slice shape with a flat bottom, fused to a purple apple-slice shape with a flat bottom on the right side of the indentation. right part: a large green apple-shaped component with a w-shaped indentation centered on top. an up-arrow is centered above the indentation pointing to a fused blue and purple apple-slice-shaped flat-bottom component sitting above the indentation. assigne "true" or "false" to the end of each statement. the model shows a shape change occurring in the enzyme after the substrate is bound in the active site. t/fthere are two products in this model. t? f there are three substrates in this model. t/f the model shows two different enzymes. t/f

Awoman whose sister tested positive for a specific mutation in the brca1 gene, which increases the risk for breast and ovarian cancer, is found not to have that mutation but does have a mutation of unknown significance near the known mutation site. how should this woman be counseled? select one: a. she should be informed that her risk for breast cancer is greater than the general population but not as great as her sister’s risk. b. she should be informed that because she does not have the mutation, her risk for breast cancer is not greater than that of the general population. c. she should be informed of her gene mutation status and be presented with all the available prophylaxis options and reconstruction options. d. she should be informed that she does not have the specific mutation but that because another mutation is present she should be vigilant about screening